Wockhardt USA Revenue and Competitors
Estimated Revenue & Valuation
- Wockhardt USA's estimated annual revenue is currently $28.9M per year.
- Wockhardt USA's estimated revenue per employee is $275,657
Employee Data
- Wockhardt USA has 105 Employees.
- Wockhardt USA grew their employee count by -2% last year.
Wockhardt USA's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Pricing and Contracts | Reveal Email/Phone |
2 | Associate Director Engineering Maintenance & Calibrations | Reveal Email/Phone |
3 | Director, Regulatory Affairs | Reveal Email/Phone |
4 | Office Manager | Reveal Email/Phone |
5 | Rebate Manager | Reveal Email/Phone |
6 | VALIDATION CHEMIST | Reveal Email/Phone |
7 | Senior Analytical Chemist | Reveal Email/Phone |
8 | Analytical Scientist | Reveal Email/Phone |
9 | Sr Accounts Receivable Analyst | Reveal Email/Phone |
10 | Demand Planner/Master Scheduler | Reveal Email/Phone |
Wockhardt USA Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 27 | 29% | N/A | N/A |
#2 | $35.8M | 156 | 6% | N/A | N/A |
#3 | $5.4M | 27 | 23% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 72 | 50% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 45 | 15% | N/A | N/A |
#8 | $10.3M | 63 | 34% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Wockhardt USA?
Wockhardt Limited created its US subsidiary Wockhardt USA in early 2004 with a modest portfolio of three FDA–approved generic products. Since inception, Wockhardt’s business has increased in the US. Today, Wockhardt USA LLC is leading the way in developing the most complete, high-quality line of generic oral solids, liquids, topicals, and injectables available in the United States. Wockhardt USA now represents more than 20% of Wockhardt Ltd’s global business, providing more than 220 NDCs spanning more than 75 different product families. We have been producing and distributing quality products in the United States for more than 14 years and have received over 110 ANDA approvals to date.\r\n\r\nChicago-based Morton Grove Pharmaceuticals was acquired by Wockhardt Limited in October 2007 in order to expand Wockhardt’s product line in the US. Since 1995, Morton Grove has been a leading manufacturer and marketer of oral liquid and topical pharmaceuticals. The company’s core products are manufactured in its 125,000 square foot, state-of-the-art facility.
keywords:N/AN/A
Total Funding
105
Number of Employees
$28.9M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Wockhardt USA News
... Key Players Jacobus Pharmaceutical, Founder Pharma, Unichem, Wockhardt ... New Jersey, USA,- The research study presented here is a very detailed and...
... Size 2022-2029| Key Players Farmhispania, Egis Pharmaceuticals, Wockhardt, Azelis Deutschland Pharma. Market Size And Forecast. New Jersey, USA,- The...
... Insulin Market Forecast 2022-2030| Key Players Akron Biotech, Wockhardt, Dance Biopharm, Novo Nordisk. Market Size And Forecast. New Jersey, USA,- The...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $39M | 105 | -2% | N/A |
#2 | $23.5M | 106 | 14% | N/A |
#3 | $21.3M | 106 | 4% | N/A |
#4 | $23.3M | 116 | 6% | N/A |
#5 | $14.8M | 116 | 23% | N/A |